Caplin Point Laboratories has informed that a meeting of the Board of Directors of the Company will be held on February 05, 2016, to consider, approve and take on record inter alia the Unaudited Financial Results for the quarter /Half year ended December 31, 2015, and to Consider and declare the payment of Interim dividend, if any for the Financial Year 2015-16. Accordingly, the Trading Window for dealing in the equity shares of the Company is closed for Promoters, Directors, other Connected Persons and Employees of the Company from December 21, 2015 to February 07,2016 as per the Company’s Code of Conduct to regulate, monitor and report trading by insiders adopted by the Board pursuant to SEBI(Prohibition of Insider Trading) Regulation,2015.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: